NCT04534127View on ClinicalTrials.gov

Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia

NARecruitingINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

December 22, 2020

Primary Completion Date

January 1, 2026

Study Completion Date

January 1, 2026

Conditions
Skin CancerMucosal Neoplasm of Oral CavitySoft Tissue Neoplasm
Interventions
DEVICE

Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT)

An intratumoral insertion of a seed(s), loaded with Radium-224, securely fixed in the seeds. The seeds release by recoil into the tumor short-lived alpha-emitting atoms.

Trial Locations (1)

91120

RECRUITING

Sharett institute, Hadassah Medical Center - Ein-Kerem, Jerusalem

Sponsors
All Listed Sponsors
lead

Alpha Tau Medical LTD.

INDUSTRY